Braulke, Friederike; Jung, Klaus; Schanz, Julie; Götze, Katharina; Müller-Thomas, Catharina; Platzbecker, Uwe; Germing, Ulrich; Brümmendorf, Tim H; Bug, Gesine; Ottmann, Oliver; Giagounidis, Aristoteles A N; Stadler, Michael; Hofmann, Wolf-Karsten; Schafhausen, Philippe; Lübbert, Michael; Schlenk, Richard F; Blau, Igor W; Ganster, Christina; Pfeiffer, Sebastian; Shirneshan, Katayoon; Metz, Michael; Detken, Sven; Seraphin, Jörg; Jentsch-Ullrich, Kathleen; Böhme, Angelika; Schmidt, Burkhard; Trümper, Lorenz; Haase, Detlef     «

Braulke, Friederike; Jung, Klaus; Schanz, Julie; Götze, Katharina; Müller-Thomas, Catharina; Platzbecker, Uwe; Germing, Ulrich; Brümmendorf, Tim H; Bug, Gesine; Ottmann, Oliver; Giagounidis, Aristoteles A N; Stadler, Michael; Hofmann, Wolf-Karsten; Schafhausen, Philippe; Lübbert, Michael; Schlenk, Richard F; Blau, Igor W; Ganster, Christina; Pfeiffer, Sebastian; Shirneshan, Katayoon; Metz, Michael; Detken, Sven; Seraphin, Jörg; Jentsch-Ullrich, Kathleen; Böhme, Angelika; Schmidt, Burkhard; Trümp...     »

The gold standard of cytogenetic analysis in myelodysplastic syndromes (MDS) is conventional chromosome banding (CCB) analysis of bone marrow (BM) metaphases. Most aberrations can also be detected by fluorescence-in situ-hybridization (FISH). For this prospective multicenter German diagnostic study (www.clinicaltrials.gov: #NCT01355913) 360 patients, as yet, were followed up to 3 years by sequential FISH analyses of immunomagnetically enriched CD34+ peripheral blood (PB) cells using comprehensive FISH probe panels, resulting in a total number of 19,516 FISH analyses. We demonstrate that CD34+ PB FISH correlates significantly with CCB analysis and represents a feasible method for a reliable non-invasive cytogenetic monitoring from PB.     «

The gold standard of cytogenetic analysis in myelodysplastic syndromes (MDS) is conventional chromosome banding (CCB) analysis of bone marrow (BM) metaphases. Most aberrations can also be detected by fluorescence-in situ-hybridization (FISH). For this prospective multicenter German diagnostic study (www.clinicaltrials.gov: #NCT01355913) 360 patients, as yet, were followed up to 3 years by sequential FISH analyses of immunomagnetically enriched CD34+ peripheral blood (PB) cells using comprehensiv...     »